Solace Secures $60M Series B Funding to Expand Digital Health Advocacy Platform

103

TL/DR –

Digital health platform Solace has raised $60m in a Series B funding round, demonstrating the increasing importance of healthcare advocacy. The funding will be used to speed up development across both the patient and advocate experiences, while expanding Solace’s national network of healthcare advocates. The round was led by Menlo Ventures and included participation from existing investors Craft Ventures, Inspired Capital and Torch Capital, as well as new investor SignalFire.


Solace Clinches $60 Million Series B Funding

Solace, the digital health platform that links patients with expert health advocates, has successfully secured a $60 million Series B funding round, signaling growing market confidence in healthcare advocacy. Founded in 2022, Solace aims to mend a flawed system and enhance health outcomes by placing humans at the core of healthcare. The funding round has reinforced Solace’s founding principle that personalized healthcare navigation is not only effective but vital.

“The healthcare industry is at a tipping point. A growing number of payers now realize that patient advocacy isn’t a support function, but a structural necessity,” states Jeremy Gurewitz, CEO and co-founder of Solace.

The funding round saw participation from Menlo Ventures, Craft Ventures, Inspired Capital and Torch Capital, with new backing from SignalFire. Solace’s EHR and data platform reduces hurdles and clarifies the modern care journey. This fresh infusion of funds will expedite development across the patient and advocate experiences as Solace scales its national healthcare advocate network.

“Our platform delivers personalized, tech-enabled advocacy that can scale, which legacy systems are unable to provide,” adds Sara Sargent, Chief Product Officer and co-founder of Solace. The funding comes alongside a period of swift expansion for Solace, underscoring a rising demand for patient-focused solutions in healthcare.

“Our investment in Solace supports our belief that healthcare advocacy will soon be a core component of modern healthcare delivery. Solace’s early data indicates not just improved patient outcomes, but also fundamentally stronger financial and clinical outcomes for payers,” says JP Sanday, Partner at Menlo Ventures.

About Solace

Solace is a digital platform that links patients with expert healthcare advocates. Launched in 2022 by co-founders Jeremy Gurewitz and Sara Sargent, Solace aims to support the millions of U.S. patients who navigate healthcare alone. Solace’s network covers all 50 U.S. states and is accepted by Medicare and major Medicare Advantage insurers, including Aetna, Blue Cross Blue Shield, Cigna, Humana, and UnitedHealthcare. For more information about Solace and the services of their advocates, visit www.solace.health.


Read More Health & Wellness News ; US News